The aim of the current study was to describe the long-term treatment outcomes and efficacy of FDG-PET for evaluating therapeutic responses among a cohort of ECD patients who were treated with IFN-α at Peking Union Medical College Hospital. The gene discussed is IFNA1; the disease is familial atrioventricular septal defect.